- Evofem Biosciences ( NASDAQ: EVFM ) on Thursday announced an agreement between Evofem and a360 media to market its contraceptive gel, Phexxi, in entertainment and lifestyle magazines and websites in the U.S.
- ( EVFM ) is up ~4% before the bell.
- a360 Media reaches 60M unique digital visitors per month and another 27M via print audiences.
- One out of every three a360 Media readers and digital users is a female between the ages of 18 and 34, making this partnership an ideal union, the company said.
For further details see:
Evofem partners with a360 media to promote Phexxi in U.S.